Uma Anand
Overview
Explore the profile of Uma Anand including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
471
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Anand U, Kirshnit C, Rea M
J Grad Med Educ
. 2024 Oct;
16(5):611-615.
PMID: 39416411
Interventions to support graduate medical education (GME) trainee well-being at the institutional level continue to be an area for continuous improvement. To assess participation, feasibility, and acceptability of a virtual,...
2.
Anand U, Schwartz R, Stonnington C
Acad Psychiatry
. 2023 Nov;
48(4):365-372.
PMID: 38017332
No abstract available.
3.
Anand U, Anand P, Sodergren M
Int J Mol Sci
. 2023 Nov;
24(22).
PMID: 38003528
Terpenes in exert analgesic effects, but the mechanisms are uncertain. We examined the effects of 10 terpenes on capsaicin responses in an established model of neuronal hypersensitivity. Adult rat DRG...
4.
Anand U, Rea M, Kirshnit C, Dias S, Molla M
J Hosp Med
. 2022 Dec;
18(8):755-757.
PMID: 36537361
No abstract available.
5.
Anand U, Pacchetti B, Anand P, Sodergren M
J Pain Res
. 2022 Nov;
15:3493-3507.
PMID: 36394060
Background: The endocannabinoid 2-Arachidonyl glycerol (2-AG) exerts dose-related anti-nociceptive effects, which are potentiated by the related but inactive 2-palmitoyl glycerol (2-PG) and 2-linoleoyl glycerol (2-LG). This potentiation of analgesia and...
6.
Anand U, Oldfield C, Pacchetti B, Anand P, Sodergren M
J Pain Res
. 2021 Dec;
14:3603-3614.
PMID: 34853533
Background: The analgesic effects of are mediated by ∆ tetrahydrocannabinol (THC), but the contributions of other bioactive complex components, including cannabigerol (CBG) and cannabidiol (CBD), are unclear. We describe the...
7.
Chochol M, Pease E, Swintak C, Anand U
Acad Psychiatry
. 2021 Jun;
45(5):581-586.
PMID: 34142351
Objective: Physicians, including psychiatrists and psychiatry trainees, are at higher risk of burnout compared to the average working population. The COVID-19 pandemic heightens this risk. This pilot aims to enhance...
8.
Anand U, Pacchetti B, Anand P, Sodergren M
Pain Manag
. 2021 Mar;
11(4):395-403.
PMID: 33703917
The recent legalization of medicinal cannabis in several jurisdictions has spurred the development of therapeutic formulations for chronic pain. Unlike pure delta-9-tetrahydrocannabinol (THC), full-spectrum products contain naturally occurring cannabinoids and...
9.
Anand U, Jones B, Korchev Y, Bloom S, Pacchetti B, Anand P, et al.
J Pain Res
. 2020 Sep;
13:2269-2278.
PMID: 32982390
Introduction: Cannabidiol (CBD) is reported to produce pain relief, but the clinically relevant cellular and molecular mechanisms remain uncertain. The TRPV1 receptor integrates noxious stimuli and plays a key role...
10.
Schwartz R, Sinskey J, Anand U, Margolis R
Ann Intern Med
. 2020 Aug;
173(12):981-988.
PMID: 32822206
Previous pandemics have seen high psychiatric morbidity among health care workers. Protecting clinician mental health in the aftermath of coronavirus disease 2019 (COVID-19) requires an evidence-based approach to developing and...